Xcout Intel
AdipoPharma competitors & alternatives
The 12 closest competitors and alternatives to AdipoPharma among biotechnology companies — ranked by similarity to what AdipoPharma actually does, not by market-cap band.
Subscribe to see AdipoPharma’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About AdipoPharma
AdipoPharma is a French biotech company dedicated to understanding the role of adipocyte cells in diabetes, focusing on lipid biosynthesis and whole-body metabolic health.
AdipoPharma at a glance
AdipoPharma is a biotechnology company headquartered in France. Its most recent funding round, Series A, closed in January 2023. Xcout tracks 11 named people at AdipoPharma, including Michael J. Fare (Chief Operating Officer).
AdipoPharma leadership
- Michael J. FareChief Operating Officer
- Catherine PerotChief Financial Officer
- Tarekegn G. HiwotChief Medical Officer
- Vincent MarionFounder, President & CEO
- Virginie BarthelDirector of Clinical Operations
- Martine BrandtOffice Manager
5 more named people on record for AdipoPharma, with roles, board committees and tenure — see the full roster →
AdipoPharma funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | Undisclosed | 3 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 AdipoPharma competitors
Ranked by semantic similarity — how close each company is to AdipoPharma by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Adipo Therapeutics is a biotechnology company developing treatments for obesity and metabolic-related diseases. The company utilizes Notch-inhibiting nanoparticles to convert energy-storing white fat into energy-burning brown fat to increase energy expenditure and resting metabolic rate.
Similar biotechnology company
Adocia is a clinical-stage biotechnology company that develops innovative formulations of proteins, peptides, and metabolic hormones. The company specializes in creating treatments for diabetes and obesity, as well as immunoprotective scaffolds for cell therapies.
Similar biotechnology company
DiogenX is a preclinical-stage biotechnology company headquartered in Marseille, France, with research laboratories in Nice, dedicated to developing novel treatments for diabetes.
Similar biotechnology company
Syntis Bio, Inc. is a clinical-stage biopharmaceutical company headquartered in Boston, Massachusetts, dedicated to revolutionizing oral therapies for obesity and metabolic diseases.
Similar biotechnology company
Carmot Therapeutics, Inc. is a biopharmaceutical company headquartered in Berkeley, California, focused on discovering and developing innovative treatments for metabolic diseases and obesity.
Biotech
Biophytis is a clinical-stage biotechnology company that develops transformational therapies to improve longevity and treat age-related diseases. The company utilizes an AI-driven research platform to discover novel drug candidates, with advanced clinical programs focusing on sarcopenia and obesity.
Similar biotechnology company
Imagine Pharma LLC is a biotechnology company that develops novel polypeptide-based platforms focused on oral delivery for biologic drugs, therapeutics for various disease states, and regenerative medicine. The company aims to create first-in-class treatments for conditions such as diabetes and wound healing, alongside offering oral peptide dietary supplements and functional ingredients for consumers.
Similar biotechnology company
Novadip Biosciences is a clinical-stage biopharmaceutical company founded in 2013 and headquartered in Belgium, focusing on innovative tissue regeneration and biopharmaceuticals.
Similar biotechnology company
Atrogi is a clinical-stage biotechnology company headquartered in Stockholm, Sweden, pioneering the development of novel treatments for metabolic disorders.
Similar biotechnology company
Parabolica Therapeutics develops proprietary peptide conjugation technologies focused on obesity and other metabolic conditions. The company researches and advances therapeutic programs through its scientific approach.
Similar biotechnology company
Inversago Pharma is a Canadian biotechnology company developing peripherally restricted CB1 receptor antagonists/inverse agonists for metabolic, fibrotic, and related diseases. Its drug-development programs are intended to serve patients with conditions such as obesity, metabolic syndrome, and diabetic kidney disease.
Similar biotechnology company
Liminal BioSciences is a biopharmaceutical company headquartered in Laval, Quebec, Canada, focused on developing innovative small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of AdipoPharma and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for AdipoPharmaand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →